- Report
- July 2021
- 50 Pages
China
From €2583EUR$2,600USD£2,148GBP
- Report
- May 2021
- 50 Pages
China
From €2583EUR$2,600USD£2,148GBP
- Report
- May 2021
- 50 Pages
China
From €2583EUR$2,600USD£2,148GBP
- Report
- May 2021
- 50 Pages
China
From €2583EUR$2,600USD£2,148GBP
- Report
- April 2021
China
From €2583EUR$2,600USD£2,148GBP
- Report
- April 2021
China
From €2583EUR$2,600USD£2,148GBP
- Report
- April 2021
- 40 Pages
China
From €2583EUR$2,600USD£2,148GBP
- Report
- April 2021
- 50 Pages
China
From €2583EUR$2,600USD£2,148GBP
- Report
- August 2019
- 30 Pages
China
From €2186EUR$2,200USD£1,817GBP
- Report
- August 2019
- 30 Pages
China
From €2186EUR$2,200USD£1,817GBP
- Report
- July 2018
- 30 Pages
China
From €2186EUR$2,200USD£1,817GBP
- Report
- October 2023
- 85 Pages
India
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- October 2023
- 107 Pages
North America
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- May 2023
- 132 Pages
United States
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- April 2023
- 145 Pages
United States
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- December 2022
- 171 Pages
Middle East, Africa
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- December 2022
- 161 Pages
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- December 2022
- 181 Pages
Asia Pacific
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- December 2022
- 186 Pages
Europe
From €2086EUR$2,100USD£1,735GBP
€2980EUR$3,000USD£2,478GBP
- Report
- August 2022
- 210 Pages
Global
From €3164EUR$3,185USD£2,631GBP
€4520EUR$4,550USD£3,758GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more